CD28 costimulation independence of target organ versus circulating memory antigen-specific CD4+ T cells

J Clin Invest. 2003 Sep;112(5):776-84. doi: 10.1172/JCI18317.

Abstract

T cell receptor engagement with CD28 costimulation is generally required for naive T cell activation, whereas reactivation of memory cells is less dependent on CD28 costimulation. We studied this process in chronic beryllium disease, in which the frequency of antigen-specific CD4+ T cells in the lung is large and circulating antigen-specific cells are also detectable. In the lung, a large fraction of CD4+ T cells stopped expressing CD28 mRNA and protein, and this change in phenotype correlated with lung inflammation. In the presence of concentrations of CTLA-4Ig that inhibited the CD28-B7 interaction, beryllium-specific CD4+ T cells in lung were still able to proliferate and secrete IFN-gamma in response to beryllium in culture. This functional independence of CD28 costimulation included lung CD28+ effector cells. Although lung CD4+CD28- cells retained the ability to secrete Th1-type cytokines in response to beryllium, they showed less proliferative capacity and were more susceptible to cell death compared with CD28+ T cells. In contrast to lung cells, inhibition of the CD28-B7 interaction markedly reduced responses of beryllium-specific T cells in blood. Taken together, these findings suggest transition within memory CD4+ T cells from CD28 dependence in central memory cells to functional independence and then loss of CD28 expression in effector cells.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Abatacept
  • Apoptosis
  • Berylliosis / immunology*
  • CD28 Antigens / blood
  • CD28 Antigens / physiology*
  • CD4-Positive T-Lymphocytes / immunology*
  • Chronic Disease
  • Humans
  • Immunoconjugates / pharmacology
  • Immunologic Memory*
  • Interferon-gamma / biosynthesis
  • Interleukin-2 / biosynthesis
  • Lymphocyte Activation

Substances

  • CD28 Antigens
  • Immunoconjugates
  • Interleukin-2
  • Abatacept
  • Interferon-gamma